The IPO market is back from its annual month-long break, with the first listings since mid-August. The hot money has come with it. Despite a broad sell-off among China stocks, three Chinese companies priced US IPOs this week. All three priced at the low...read more
Principia Biopharma, which is developing oral small molecule therapies for pemphigus, immune thrombocytopenic purpura and MS, raised $106 million by offering 6.3 million shares at $17, the high end of the range of $15 to $17. Insiders intend to...read more
Principia Biopharma, which is developing oral small molecule therapies for pemphigus, ITP and MS, raised the proposed deal size for its upcoming IPO on Thursday. The South San Francisco, CA-based company now plans to raise $100 million by offering 6.3...read more
Five IPOs are scheduled to raise $1.6 billion in the week ahead, the first batch since mid-August. As we highlighted in our Fall Preview, China is kick-starting Post-Labor Day deal flow:...read more
US IPO Weekly Recap: IPO market returns from vacation with a 128% pop
The IPO market is back from its annual month-long break, with the first listings since mid-August. The hot money has come with it. Despite a broad sell-off among China stocks, three Chinese companies priced US IPOs this week. All three priced at the low...read more
Small molecule biotech Principia Biopharma prices IPO at $17, the high end of the range
Principia Biopharma, which is developing oral small molecule therapies for pemphigus, immune thrombocytopenic purpura and MS, raised $106 million by offering 6.3 million shares at $17, the high end of the range of $15 to $17. Insiders intend to...read more
Small molecule biotech Principia Biopharma increases proposed IPO deal size
Principia Biopharma, which is developing oral small molecule therapies for pemphigus, ITP and MS, raised the proposed deal size for its upcoming IPO on Thursday. The South San Francisco, CA-based company now plans to raise $100 million by offering 6.3...read more
US IPO Week Ahead: Fall IPO market starts up with 5 deals led by China's NIO
Five IPOs are scheduled to raise $1.6 billion in the week ahead, the first batch since mid-August. As we highlighted in our Fall Preview, China is kick-starting Post-Labor Day deal flow:...read more